Page last updated: 2024-08-25

adriamycinol and Hematologic Malignancies

adriamycinol has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fernández de Gatta, Mdel M; García Sánchez, MJ; González López, F; Hernández-Rivas, JM; Pérez-Blanco, JS; Sayalero Marinero, ML	1

Other Studies

1 other study(ies) available for adriamycinol and Hematologic Malignancies

Article	Year
Validation and clinical evaluation of a UHPLC method with fluorescence detector for plasma quantification of doxorubicin and doxorubicinol in haematological patients. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2014, Apr-01, Volume: 955-956 Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Doxorubicin; Drug Monitoring; Drug Stability; Hematologic Neoplasms; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity	2014

Article

Year

Validation and clinical evaluation of a UHPLC method with fluorescence detector for plasma quantification of doxorubicin and doxorubicinol in haematological patients.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2014, Apr-01, Volume: 955-956

Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Doxorubicin; Drug Monitoring; Drug Stability; Hematologic Neoplasms; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity

2014